Why the study?
Does intravenous diphenylhydantoin affect left ventricular function in patients with heart disease?
Does intravenous diphenylhydantoin affect left ventricular function in patients with heart disease?
Intravenous diphenylhydantoin causes a transient, clinically insignificant depression of myocardial function without significant systemic hypotension.
Answers are grounded in this paper and cite their sources.
Transient myocardial effects support monitoring during IV use in heart disease; leaves open safety in larger controlled cohorts.
The effect of 250 mg of diphenylhydantoin, administered intravenously, on left ventricular function was determined during cardiac catheterization in nine patients with heart disease. Five minutes after drug administration, left ventricular end-diastolic pressure rose in each patient from an average of 6.0 mm Hg to 10.0 mm Hg. Concurrently, stroke work and stroke power indices decreased in each patient by an average of 22.0% and 22.2%, respectively. Stroke volume index decreased in seven patients and maximum left ventricular dp/dt fell in eight patients. Over the next 25 minutes, all parameters returned to control values. Cardiac index was unchanged, whereas generally small and insignificant changes were observed in heart rate and systemic arterial pressure throughout the study. Although this study has demonstrated that diphenylhydantoin depresses myocardial function, the effect may have limited clinical significance since it was relatively short-lived and did not reduce cardiac output or greatly elevate ventricular end-diastolic pressure. Furthermore, the absence of a significant systemic hypotensive effect is of distinct clinical importance.
No takes yet. Share an insight, caveat, or question.
LIEBERSON et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: